The European College of Neuropsychopharmacology has announced Professor Andreas Meyer-Lindenberg, Director of the Central Institute of Mental Health in Mannheim, and Chair of Psychiatry at the University of Heidelberg, as the new editor-in-chief of European Neuropsychopharmacology (ENP), the official journal of the European College of Neuropsychopharmacology (ECNP). Meyer-Lindenberg was jointly appointed by the College and the journal's publisher Elsevier, for a three year term. He takes over from Professor Michael Davidson, MD, Chairman of Psychiatry at Tel Aviv University, who led the journal for the maximum term of six years and presided over a strong increase in the journals impact and reach.
The European College of Neuropsychopharmacology (ECNP) is Europe's leading interdisciplinary forum for the science and treatment of disorders of the brain. In its mission to promote the communication and cross- fertilisation of high-quality experimental and clinical research across the field of neuroscience, the journal ENP plays a critical role.
Meyer-Lindenberg's research interests focus on the development of novel treatments for severe psychiatric disorders, especially schizophrenia, through an application of multimodal neuroimaging, genetics and environmental science to characterize brain circuits underlying the risk for mental illness and cognitive dysfunction. He is a member of the Executive Board of the ECNP and has been an Associate Editor of the journal for four years prior to his appointment.
